Physician profile
Jose A Cortes
NPI 1710077409
$183,575.19
in general payments reported to CMS, 2019-2025
51 companies · $86K in 2025
The $86K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $10K · 2021: $7,236 · 2022: $14K · 2023: $22K · 2024: $3,419 · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Travel and Lodging: $16K · Food and Beverage: $14K · Education: $44.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,607.50 |
| Travel and Lodging | $15,721.16 |
| Food and Beverage | $14,372.53 |
| Education | $44.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $124,141.79 | 2019-2025 | Descovy, Yeztugo, Biktarvy |
| Viiv Healthcare Company | $48,264.47 | 2019-2025 | Apretude, Dovato, Cabenuva |
| Merck Sharp & Dohme LLC | $1,675.58 | 2019-2025 | Pifeltro, Dificid, Zerbaxa |
| Astrazeneca Pharmaceuticals Lp | $1,367.81 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $1,201.58 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Janssen Biotech, INC. | $749.03 | 2019-2023 | Symtuza |
| Novo Nordisk INC | $606.91 | 2022-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $603.60 | 2019-2024 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $597.75 | 2019-2025 | Jardiance |
| Abbvie INC. | $405.67 | 2021-2025 | Viberzi, Linzess |
| Astellas Pharma US INC | $372.42 | 2019-2025 | Veozah |
| Insmed, INC. | $331.09 | 2019-2021 | |
| Amgen INC. | $241.75 | 2019-2025 | Repatha, Otezla, Otezla |
| Theratechnologies INC. | $218.62 | 2019-2025 | Trogarzo, Egrifta |
| Paratek Pharmaceuticals, INC. | $217.40 | 2020-2024 | Nuzyra |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $194.37 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $189.31 | 2022-2024 | |
| Bausch Health US, LLC | $181.73 | 2022-2024 | Aplenzin, Wellbutrin |
| Otsuka America Pharmaceutical, INC. | $180.66 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $178.57 | 2024-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $175.46 | 2024-2025 | Auvelity |
| Glaxosmithkline, LLC. | $161.26 | 2020-2025 | Shingrix, Arexvy |
| Lundbeck LLC | $128.20 | 2024-2025 | Rexulti |
| Abbott Laboratories | $102.23 | 2022-2024 | Freestyle Libre 3 |
| Napo Pharmaceuticals INC | $91.29 | 2019 | |
| Ardelyx, INC. | $83.65 | 2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $82.39 | 2025 | Voquezna |
| Horizon Therapeutics Plc | $74.84 | 2020-2022 | |
| Janssen Products, Lp | $69.99 | 2021 | |
| Idorsia Pharmaceuticals US INC | $62.65 | 2022-2023 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $55.86 | 2023-2024 | Eliquis, Camzyos |
| Ironwood Pharmaceuticals, INC | $55.07 | 2024 | |
| Smith+Nephew, INC. | $43.67 | 2020-2025 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $38.67 | 2023-2024 | Vabomere, Kimyrsa, Rezzayo |
| Renalytix Ai, INC. | $38.37 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Shionogi INC | $36.08 | 2021 | |
| Pfizer INC. | $35.02 | 2022-2025 | |
| Mylan Institutional INC. | $30.81 | 2019 | |
| Almatica Pharma LLC | $29.79 | 2025 | Loreev Xr |
| Madrigal Pharmaceuticals | $29.42 | 2025 | Rezdiffra |
| Emd Serono, INC. | $29.17 | 2020 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Alk-Abello, INC | $25.30 | 2025 | Neffy |
| Scilex Pharmaceuticals INC. | $22.23 | 2021 | |
| Recordati_rare_diseases_inc. | $20.32 | 2024 | Sylvant |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.09 | 2022 | |
| Esperion Therapeutics, INC. | $19.74 | 2023 | Nexletol |
| Hologic Sales and Service, LLC | $17.75 | 2023 | Aptima |
| Seqirus USA INC | $17.29 | 2021 | |
| Zimmer Biomet Holdings, INC. | $15.67 | 2024 | |
| Genentech USA, INC. | $14.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Cortes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.